• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Chronic kidney disease measures and the risk of abdominal aortic aneurysm.慢性肾脏病评估与腹主动脉瘤风险。
Atherosclerosis. 2018 Dec;279:107-113. doi: 10.1016/j.atherosclerosis.2018.08.043. Epub 2018 Sep 1.
2
Kidney Disease Measures and Left Ventricular Structure and Function: The Atherosclerosis Risk in Communities Study.肾脏病指标与左心室结构和功能:社区动脉粥样硬化风险研究。
J Am Heart Assoc. 2017 Sep 22;6(9):e006259. doi: 10.1161/JAHA.117.006259.
3
Associations Between Kidney Disease Measures and Regional Pulse Wave Velocity in a Large Community-Based Cohort: The Atherosclerosis Risk in Communities (ARIC) Study.在一个大型社区队列中,肾脏疾病指标与区域脉搏波速度的相关性:动脉粥样硬化风险社区(ARIC)研究。
Am J Kidney Dis. 2018 Nov;72(5):682-690. doi: 10.1053/j.ajkd.2018.04.018. Epub 2018 Jul 12.
4
Particulate Matter and Albuminuria, Glomerular Filtration Rate, and Incident CKD.颗粒物与蛋白尿、肾小球滤过率和新发慢性肾脏病。
Clin J Am Soc Nephrol. 2020 Mar 6;15(3):311-319. doi: 10.2215/CJN.08350719. Epub 2020 Feb 27.
5
Albuminuria, Proteinuria, and Renal Disease Progression in Children with CKD.慢性肾脏病患儿的白蛋白尿、蛋白尿与肾脏疾病进展
Clin J Am Soc Nephrol. 2017 Jun 7;12(6):912-920. doi: 10.2215/CJN.11971116. Epub 2017 May 25.
6
Albuminuria and Estimated GFR as Risk Factors for Dementia in Midlife and Older Age: Findings From the ARIC Study.白蛋白尿和估计肾小球滤过率作为中年和老年痴呆风险因素:来自 ARIC 研究的发现。
Am J Kidney Dis. 2020 Dec;76(6):775-783. doi: 10.1053/j.ajkd.2020.03.015. Epub 2020 May 16.
7
Prevalence of chronic kidney disease defined by using CKD-EPI equation and albumin-to-creatinine ratio in the Korean adult population.使用CKD-EPI方程和白蛋白与肌酐比值定义的慢性肾脏病在韩国成年人群中的患病率。
Korean J Intern Med. 2016 Nov;31(6):1120-1130. doi: 10.3904/kjim.2015.193. Epub 2016 Mar 25.
8
Risk Factors for Heart Failure in Patients With Chronic Kidney Disease: The CRIC (Chronic Renal Insufficiency Cohort) Study.慢性肾脏病患者心力衰竭的危险因素:CRIC(慢性肾功能不全队列)研究
J Am Heart Assoc. 2017 May 17;6(5):e005336. doi: 10.1161/JAHA.116.005336.
9
Chronic Kidney Disease and Risk for Gastrointestinal Bleeding in the Community: The Atherosclerosis Risk in Communities (ARIC) Study.社区中慢性肾脏病与胃肠道出血风险:社区动脉粥样硬化风险(ARIC)研究
Clin J Am Soc Nephrol. 2016 Oct 7;11(10):1735-1743. doi: 10.2215/CJN.02170216. Epub 2016 Aug 11.
10
Measures of chronic kidney disease and risk of incident peripheral artery disease: a collaborative meta-analysis of individual participant data.慢性肾脏病的衡量指标与新发外周动脉疾病风险:个体参与者数据的协作荟萃分析。
Lancet Diabetes Endocrinol. 2017 Sep;5(9):718-728. doi: 10.1016/S2213-8587(17)30183-3. Epub 2017 Jul 14.

引用本文的文献

1
Changes in urinary albumin levels with dotinurad oral administration in hyperuricemic patients with microalbuminuria: a post hoc analysis.微白蛋白尿高尿酸血症患者口服度洛尿酸后尿白蛋白水平的变化:一项事后分析
Clin Exp Nephrol. 2025 Aug 21. doi: 10.1007/s10157-025-02750-4.
2
Ferumoxytol-enhanced magnetic resonance angiography for endovascular aortic repair surveillance in a patient after renal transplant.肾移植术后患者使用铁羧麦芽糖增强磁共振血管造影术进行血管腔内主动脉修复监测
J Vasc Surg Cases Innov Tech. 2025 Jun 26;11(5):101898. doi: 10.1016/j.jvscit.2025.101898. eCollection 2025 Oct.
3
Proteinuria is risk factor for abdominal aortic aneurysm: a nationwide population-based study.蛋白尿是腹主动脉瘤的危险因素:一项基于全国人群的研究。
BMC Public Health. 2025 May 23;25(1):1897. doi: 10.1186/s12889-025-22989-6.
4
Serum Creatinine Level in Relation to Intraluminal Thrombus and Abdominal Aortic Aneurysm Size.血清肌酐水平与腔内血栓及腹主动脉瘤大小的关系。
J Clin Med. 2025 Feb 14;14(4):1258. doi: 10.3390/jcm14041258.
5
2024 Guidelines of the Taiwan Society of Cardiology on the Primary Prevention of Atherosclerotic Cardiovascular Disease --- Part I.2024年台湾心脏病学会动脉粥样硬化性心血管疾病一级预防指南——第一部分
Acta Cardiol Sin. 2024 Sep;40(5):479-543. doi: 10.6515/ACS.202409_40(5).20240724A.
6
Chronic Kidney Disease Associated with Ischemic Heart Disease: To What Extent Do Biomarkers Help?与缺血性心脏病相关的慢性肾脏病:生物标志物有多大帮助?
Life (Basel). 2023 Dec 25;14(1):34. doi: 10.3390/life14010034.
7
Cardiovascular outcomes and safety of SGLT2 inhibitors in chronic kidney disease patients.SGLT2 抑制剂在慢性肾脏病患者中的心血管结局和安全性。
Front Endocrinol (Lausanne). 2023 Nov 16;14:1236404. doi: 10.3389/fendo.2023.1236404. eCollection 2023.
8
Cardiovascular complications in chronic kidney disease: a review from the European Renal and Cardiovascular Medicine Working Group of the European Renal Association.慢性肾脏病的心血管并发症:来自欧洲肾脏病协会的欧洲肾脏和心血管医学工作组的综述。
Cardiovasc Res. 2023 Sep 5;119(11):2017-2032. doi: 10.1093/cvr/cvad083.
9
Impact of in patients with abdominal aortic aneurysm: a cross-sectional study.腹主动脉瘤患者中[具体因素]的影响:一项横断面研究。 (你提供的原文中“of”后面缺少具体内容)
Biosci Microbiota Food Health. 2023;42(1):81-86. doi: 10.12938/bmfh.2022-055. Epub 2022 Oct 3.
10
Chronic kidney disease as a risk factor for abdominal aortic aneurysm: a nationwide population-based study.慢性肾病作为腹主动脉瘤的一个风险因素:一项基于全国人口的研究。
Ann Surg Treat Res. 2022 Nov;103(5):297-305. doi: 10.4174/astr.2022.103.5.297. Epub 2022 Nov 1.

本文引用的文献

1
Association of Matrix Metalloproteinase Levels with Collagen Degradation in the Context of Abdominal Aortic Aneurysm.腹主动脉瘤背景下基质金属蛋白酶水平与胶原蛋白降解的关联
Eur J Vasc Endovasc Surg. 2017 Apr;53(4):549-558. doi: 10.1016/j.ejvs.2016.12.030. Epub 2017 Feb 10.
2
Heart Disease and Stroke Statistics-2017 Update: A Report From the American Heart Association.《2017年心脏病和中风统计数据更新:美国心脏协会报告》
Circulation. 2017 Mar 7;135(10):e146-e603. doi: 10.1161/CIR.0000000000000485. Epub 2017 Jan 25.
3
Impact of Indoxyl Sulfate on Progenitor Cell-Related Neovascularization of Peripheral Arterial Disease and Post-Angioplasty Thrombosis of Dialysis Vascular Access.硫酸吲哚酚对周围动脉疾病祖细胞相关新生血管形成及透析血管通路血管成形术后血栓形成的影响。
Toxins (Basel). 2017 Jan 7;9(1):25. doi: 10.3390/toxins9010025.
4
Lifetime Risk and Risk Factors for Abdominal Aortic Aneurysm in a 24-Year Prospective Study: The ARIC Study (Atherosclerosis Risk in Communities).一项为期24年的前瞻性研究:社区动脉粥样硬化风险研究(ARIC研究)中腹主动脉瘤的终生风险及风险因素
Arterioscler Thromb Vasc Biol. 2016 Dec;36(12):2468-2477. doi: 10.1161/ATVBAHA.116.308147. Epub 2016 Nov 10.
5
Matrix metalloproteinase 9-dependent Notch signaling contributes to kidney fibrosis through peritubular endothelial-mesenchymal transition.基质金属蛋白酶9依赖性Notch信号通过肾小管周围内皮-间充质转化促进肾纤维化。
Nephrol Dial Transplant. 2017 May 1;32(5):781-791. doi: 10.1093/ndt/gfw308.
6
Role of Myeloperoxidase in Patients with Chronic Kidney Disease.髓过氧化物酶在慢性肾脏病患者中的作用
Oxid Med Cell Longev. 2016;2016:1069743. doi: 10.1155/2016/1069743. Epub 2016 Apr 3.
7
Role of matrix metalloproteinase-9 in chronic kidney disease: a new biomarker of resistant albuminuria.基质金属蛋白酶-9在慢性肾脏病中的作用:抵抗性蛋白尿的一种新生物标志物。
Clin Sci (Lond). 2016 Apr 1;130(7):525-38. doi: 10.1042/CS20150517. Epub 2016 Jan 5.
8
Circulating Biomarkers and Abdominal Aortic Aneurysm Incidence: The Atherosclerosis Risk in Communities (ARIC) Study.循环生物标志物与腹主动脉瘤发病率:社区动脉粥样硬化风险(ARIC)研究
Circulation. 2015 Aug 18;132(7):578-85. doi: 10.1161/CIRCULATIONAHA.115.016537. Epub 2015 Jun 17.
9
Estimated glomerular filtration rate and albuminuria for prediction of cardiovascular outcomes: a collaborative meta-analysis of individual participant data.估算肾小球滤过率和尿白蛋白排泄率对心血管结局的预测作用:个体参与者数据的协作荟萃分析。
Lancet Diabetes Endocrinol. 2015 Jul;3(7):514-25. doi: 10.1016/S2213-8587(15)00040-6. Epub 2015 May 28.
10
Screening for abdominal aortic aneurysm: U.S. Preventive Services Task Force recommendation statement.筛查腹主动脉瘤:美国预防服务工作组推荐声明。
Ann Intern Med. 2014 Aug 19;161(4):281-90. doi: 10.7326/M14-1204.

慢性肾脏病评估与腹主动脉瘤风险。

Chronic kidney disease measures and the risk of abdominal aortic aneurysm.

机构信息

Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.

Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.

出版信息

Atherosclerosis. 2018 Dec;279:107-113. doi: 10.1016/j.atherosclerosis.2018.08.043. Epub 2018 Sep 1.

DOI:10.1016/j.atherosclerosis.2018.08.043
PMID:30290962
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6295219/
Abstract

BACKGROUND AND AIMS

Despite its strong link to cardiovascular outcomes, the association of chronic kidney disease (CKD) with abdominal aortic aneurysm (AAA) has not been explicitly and comprehensively investigated.

METHODS

In 10,724 participants in the Atherosclerosis Risk in Communities Study (aged 53-75 years during 1996-1998), we evaluated the associations of two key CKD measures - estimated glomerular filtration rate (eGFR) and urine albumin-to-creatinine ratio (ACR) - with incident AAA (AAA diagnosis in outpatient, hospitalization discharge, or death records). Additionally, we performed a cross-sectional analysis for the CKD measures and ultrasound-based abdominal aortic diameter in 4258 participants during 2011-2013.

RESULTS

During a median follow-up of 13.9 years, 347 participants developed AAA. The demographically-adjusted hazard ratio (HR) was 4.44 (95% CI 1.58-12.49) for eGFR <30, 3.29 (1.89-5.72) for 30-44, 2.03 (1.29-3.19) for 45-59, and 1.62 (1.11-2.35) for 60-74 compared to eGFR ≥90 mL/min/1.73 m and was 2.49 (1.28-4.87) for ACR ≥300, 1.99 (1.40-2.83) for 30-299, and 1.46 (1.08-1.97) for 10-29 compared to ACR <10 mg/g. The associations were generally similar after accounting for additional confounders, such as smoking (although attenuated), or after stratifying by subgroups, including diabetes. The cross-sectional analysis also showed continuous positive associations of these CKD measures with aortic diameter, particularly at the distal aortic segment assessed.

CONCLUSIONS

Reduced eGFR and elevated albuminuria were independently associated with greater incidence of AAA and greater abdominal aortic diameter. Our results suggest the potential usefulness of CKD measures to identify persons at high risk of AAA and the need to investigate pathophysiological pathways linking CKD to AAA.

摘要

背景与目的

尽管慢性肾脏病(CKD)与腹主动脉瘤(AAA)之间存在密切关联,但目前尚未对其进行明确且全面的研究。

方法

在 10724 名参加动脉粥样硬化风险社区研究(1996-1998 年期间年龄在 53-75 岁之间)的参与者中,我们评估了两种关键的 CKD 指标——估算肾小球滤过率(eGFR)和尿白蛋白与肌酐比值(ACR)——与新发 AAA(AAA 的诊断依据为门诊、住院出院或死亡记录)之间的相关性。此外,我们还对 2011-2013 年期间的 4258 名参与者进行了 CKD 指标和基于超声的腹主动脉直径的横断面分析。

结果

在中位随访 13.9 年期间,347 名参与者发生了 AAA。在调整了人口统计学因素后,eGFR<30 的 HR 为 4.44(95%CI 1.58-12.49),30-44 的 HR 为 3.29(1.89-5.72),45-59 的 HR 为 2.03(1.29-3.19),60-74 的 HR 为 1.62(1.11-2.35),与 eGFR≥90 mL/min/1.73 m 相比;ACR≥300 的 HR 为 2.49(1.28-4.87),30-299 的 HR 为 1.99(1.40-2.83),10-29 的 HR 为 1.46(1.08-1.97),与 ACR<10mg/g 相比。在考虑了其他混杂因素(如吸烟情况,尽管有所减弱),或在按亚组(包括糖尿病)分层后,这些相关性基本保持一致。横断面分析还显示,这些 CKD 指标与主动脉直径呈连续正相关,特别是在评估的远端主动脉节段。

结论

eGFR 降低和白蛋白尿升高与 AAA 的发生率增加和腹主动脉直径增大独立相关。我们的研究结果表明,CKD 指标可能有助于识别 AAA 高危人群,有必要研究 CKD 与 AAA 之间的病理生理途径。